Impact of renin-angiotensin system inhibitors on outcomes in patients with metastatic renal cell carcinoma treated with immune-checkpoint inhibitors
Pier Vitale Nuzzo, Elio Adib, Nicole Weise, Catherine Curran, Tyler F. Stewart, Dory Freeman, Amin H. Nassar, Sarah Abou Alaiwi, Ziad Bakouny, Bradley A. McGregor, Toni K. Choueiri, Rakesh K. Jain, Rana R. McKay, Guru Sonpavde
Topics & Concepts
MedicineCohortTolerabilityInternal medicineRenal cell carcinomaOncologyNivolumabRetrospective cohort studyCancerAdverse effectImmunotherapyRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis